-
公开(公告)号：US20230233506A1
公开(公告)日：2023-07-27
申请号：US18114305
申请日：2023-02-27
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/4422 , A61K31/5415 , A61K31/00 , A61K31/554
CPC分类号： A61K31/277 , A61K31/00 , A61K31/554 , A61K31/4422 , A61K31/5415
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeatic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of vital protein transistion, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolic thereof, a calmodulin blocker and a metabolite thereof, and a plumaceutical acceptable diluent or carrier: and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US10350190B2
公开(公告)日：2019-07-16
申请号：US13513639
申请日：2010-12-03
申请人： Kenneth W. Adams
发明人： Kenneth W. Adams
IPC分类号： A61K31/00 , A61K31/277 , A61K31/554 , A61K31/4422 , A61K31/5415
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US20210128514A1
公开(公告)日：2021-05-06
申请号：US17146010
申请日：2021-01-11
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/00 , A61K31/4422 , A61K31/5415 , A61K31/554
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, of calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier, and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US10888541B2
公开(公告)日：2021-01-12
申请号：US16423225
申请日：2019-05-28
发明人： Kenneth W. Adams
IPC分类号： A61K31/277 , A61K31/00 , A61K31/4422 , A61K31/5415 , A61K31/554
摘要： In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
-
公开(公告)号：US10709882B2
公开(公告)日：2020-07-14
申请号：US13519909
申请日：2010-12-03
申请人： Kenneth W. Adams
发明人： Kenneth W. Adams
摘要： A method and device to deliver medication in a liquid, gel or suspension formulation to a plurality of adjacent tissue sites of a mammal, the device comprising a plurality of tissue-engaging members for receiving the medication and operably engageable with the plurality of tissue sites; means for supplying the tissue-engaging members with the formulation, and to temporarily sustain and control the rate of therapeutic agent/unit of time and preferably to sustain these controlled delivery rates over extended periods of time to enhance the local therapeutic effect of these therapeutic agents and to reduce the systemic toxicity and reduce unwanted side effects.
-
-
-
-
搜索结果
5 条记录 (耗时 0.016 秒)
